🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#Innovation requires partnerships between govt, NGOs and industry. Mark Fladrich speaking about what Grünenthal are doing to make #chronicpain #research more #patient centred

New research collaboration to develop novel therapies for patients suffering from Charcot-Marie-Tooth 1A (CMT1A), an inherited neurological disorder: bit.ly/2Mr9JMy MaxPlanck-Innovation Max Planck Society Grünenthal

Grupo Grünenthal Ecuador y Universidad de Especialidades Espíritu Santo crean conjuntamente un proyecto innovador en Samborondón. Boletín de prensa: bit.ly/2OgSWfS Cancillería del Ecuador 🇪🇨

More than a year in the making, here are our #EUHPP partners presenting our Joint Statement to Commissioner Vytenis Andriukaitis. Thank you again to EU One Health and everyone who contributed for helping make this happen. Together, let's improve #chronicpain in the EU.

"Everybody deserves a life free of #pain and its physical, emotional and societal burdens" Gabriel Baertschi, CEO Grünenthal #WeWontRest #PatientEngagement bit.ly/2O2h4aJ

"Today, to treat pain, a #multidisciplinary team is needed, which can help the person physically, psychologically and even socially." Dr. César Margarit introduces #impactofpain and why #chronicpain requires a multi-stakeholder approach.

Great to see clinicians and researchers share #chronicpain management best practice at #sipespaña2018. Here's Encarnacion Cuellar presenting the “Andalusian Pain Plan”, how they coordinate pain care across the region.

Investment in research on the #impactofpain is important. Our SIP Joint Statement requests to identify and analyse gaps in national and European funding for #painresearch. #EUHPP ➡️Read and endorse the Joint Statement here: bit.ly/2QoFU1x